|
US5637770A
(en)
|
1991-01-16 |
1997-06-10 |
Daiichi Pharmaceutical Co., Ltd. |
Hexa-cyclic compound
|
|
US6504029B1
(en)
|
1995-04-10 |
2003-01-07 |
Daiichi Pharmaceutical Co., Ltd. |
Condensed-hexacyclic compounds and a process therefor
|
|
AP866A
(en)
|
1995-08-02 |
2000-08-17 |
Newcastle Univ Ventures Limited |
Benzimidazole compounds.
|
|
EP0897924B1
(en)
|
1996-04-26 |
2001-10-31 |
Daiichi Pharmaceutical Co., Ltd. |
Process for the preparation of tetrahydro-indolizines
|
|
TW409058B
(en)
|
1996-06-06 |
2000-10-21 |
Daiichi Seiyaku Co |
Method for preparation of a drug complex
|
|
TW527183B
(en)
|
1996-06-06 |
2003-04-11 |
Daiichi Seiyaku Co |
Drug complex
|
|
IN189180B
(es)
|
1997-07-09 |
2003-01-04 |
Chong Kun Dang Corp |
|
|
CN1250293C
(zh)
|
1998-05-22 |
2006-04-12 |
第一制药株式会社 |
药物复合物
|
|
BR9915198A
(pt)
|
1998-10-30 |
2001-08-14 |
Daiichi Seiyaku Co |
Composto dds e método para medição do mesmo
|
|
TR200101239T2
(tr)
|
1998-11-03 |
2001-11-21 |
Basf Aktiengesellschaft |
İkameli-2-fenilbenzimidazoller, üretimleri ve kullanımları
|
|
OA11749A
(en)
|
1999-01-11 |
2005-07-19 |
Agouron Pharma |
Tricyclic inhibitors of poly(adp-ribose)polymerases.
|
|
DE19920936A1
(de)
|
1999-05-07 |
2000-11-09 |
Basf Ag |
Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung
|
|
ECSP003637A
(es)
|
1999-08-31 |
2002-03-25 |
Agouron Pharma |
Inhibidores triciclicos de poli (adp-ribosa) polimerasas
|
|
US6699876B2
(en)
|
1999-11-18 |
2004-03-02 |
Les Laboratoires Servier |
Camptothecin analogue compounds
|
|
CA2396513A1
(en)
|
1999-12-13 |
2001-06-14 |
Yanzhi Zhang |
Pseudomycin phosphate prodrugs
|
|
EP1308171A1
(en)
|
2000-07-13 |
2003-05-07 |
Daiichi Pharmaceutical Co., Ltd. |
Pharmaceutical compositions containing dds compounds
|
|
US7151102B2
(en)
|
2000-10-30 |
2006-12-19 |
Kudos Pharmaceuticals Limited |
Phthalazinone derivatives
|
|
US7771727B2
(en)
|
2002-03-01 |
2010-08-10 |
The Administrators Of The Tulane Educational Fund |
Conjugates of therapeutic or cytotoxic agents and biologically active peptides
|
|
GEP20074230B
(en)
|
2002-03-20 |
2007-11-12 |
Bristol Myers Squibb Co |
Phosphate prodrugs of fluorooxindoles
|
|
DE60335359D1
(de)
|
2002-04-30 |
2011-01-27 |
Kudos Pharm Ltd |
Phthalazinonderivate
|
|
US7449464B2
(en)
|
2003-03-12 |
2008-11-11 |
Kudos Pharmaceuticals Limited |
Phthalazinone derivatives
|
|
JP2006522088A
(ja)
|
2003-03-31 |
2006-09-28 |
ファイザー・インク |
ポリ（ａｄｐ−リボース）ポリメラーゼの三環系阻害剤の塩
|
|
CA2930485C
(en)
|
2003-05-14 |
2018-04-10 |
Immunogen, Inc. |
Maytansinoid-antibody conjugate compositions
|
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
SI3524611T1
(sl)
|
2003-05-20 |
2021-05-31 |
Immunogen, Inc. |
Izboljšana citotoksična sredstva, ki vsebujejo nove majtanzinoide
|
|
ES2339663T3
(es)
|
2003-07-25 |
2010-05-24 |
Cancer Research Technology Limited |
Inhibidores de parp triciclicos.
|
|
GB0317466D0
(en)
|
2003-07-25 |
2003-08-27 |
Univ Sheffield |
Use
|
|
PL1684736T3
(pl)
|
2003-12-01 |
2012-01-31 |
Kudos Pharm Ltd |
Inhibitory naprawy DNA w leczeniu raka
|
|
AU2005216251B2
(en)
|
2004-02-23 |
2011-03-10 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
US8288557B2
(en)
*
|
2004-07-23 |
2012-10-16 |
Endocyte, Inc. |
Bivalent linkers and conjugates thereof
|
|
KR20080097497A
(ko)
|
2004-09-22 |
2008-11-05 |
화이자 인코포레이티드 |
폴리(ａｄｐ-리보오스) 폴리머라제 억제제의 제조 방법
|
|
MX2007003314A
(es)
|
2004-09-22 |
2007-08-06 |
Pfizer |
Combinaciones terapeuticas que comprenden inhibidor de poli(adp-ribosa)polimerasas.
|
|
WO2006033007A2
(en)
|
2004-09-22 |
2006-03-30 |
Pfizer Inc. |
Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
|
|
NZ555601A
(en)
|
2004-12-09 |
2009-07-31 |
Centocor Inc |
Anti-integrin immunoconjugates, methods and uses
|
|
ES2399267T3
(es)
|
2005-01-18 |
2013-03-27 |
The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations |
Suministro selectivo de moléculas al interior de las células o marcación de células en zonas enfermas de tejidos usando un péptido transmembrana sensible a su entorno
|
|
US7301019B2
(en)
|
2005-01-21 |
2007-11-27 |
Immunogen, Inc. |
Method for the preparation of maytansinoid esters
|
|
US20060182750A1
(en)
|
2005-02-11 |
2006-08-17 |
Immunogen, Inc. |
Process for preparing stable drug conjugates
|
|
EA200702239A1
(ru)
|
2005-04-15 |
2008-10-30 |
Иммьюноджен, Инк. |
Уничтожение гетерогенной или смешанной клеточной популяции в опухолях
|
|
CA2893252C
(en)
|
2005-08-24 |
2018-05-29 |
Immunogen, Inc. |
Process for preparing antibody maytansinoid conjugates
|
|
WO2007041357A1
(en)
|
2005-09-29 |
2007-04-12 |
Abbott Laboratories |
1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors
|
|
EP1945647B9
(en)
|
2005-11-08 |
2012-11-14 |
Immunogen, Inc. |
Processes for preparation of maytansinol
|
|
EP2338487B1
(en)
|
2006-01-17 |
2013-09-11 |
Abbott Laboratories |
Combination therapy with PARP inhibitors
|
|
UY30639A1
(es)
|
2006-10-17 |
2008-05-31 |
Kudos Pharm Ltd |
Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
|
|
RS51780B
(en)
|
2007-01-10 |
2011-12-31 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.R.L. |
INDASOLS SUBSTITUTED BY AMIDE AS INHIBITORS OF POLY (ADP-Ribose) POLYMERASES (PARP)
|
|
WO2008114114A2
(en)
|
2007-03-16 |
2008-09-25 |
Pfizer Products Inc. |
Poly(adp-ribose) polymerases inhibitor for treating ophthalmic condition
|
|
CN104383553A
(zh)
*
|
2007-06-25 |
2015-03-04 |
恩多塞特公司 |
含有亲水性间隔区接头的共轭物
|
|
US8067613B2
(en)
|
2007-07-16 |
2011-11-29 |
Abbott Laboratories |
Benzimidazole poly(ADP ribose)polymerase inhibitors
|
|
US9193763B2
(en)
*
|
2007-08-17 |
2015-11-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
CA2722109A1
(en)
|
2008-04-30 |
2009-11-05 |
Immunogen, Inc. |
Potent conjugates and hydrophilic linkers
|
|
CN104984360A
(zh)
|
2009-06-03 |
2015-10-21 |
伊缪诺金公司 |
轭合方法
|
|
US9353140B2
(en)
|
2009-11-25 |
2016-05-31 |
Academia Sinica |
BQC-G, a tumor-selective anti-cancer prodrug
|
|
SI2534153T1
(sl)
|
2010-02-12 |
2017-01-31 |
Pfizer Inc. |
Soli in polimorfi 8-fluoro-2-(4-((metilamino)metil)fenil)-1,3,4,5-tetrahidro-6H-azepino (5,4,3-cd)indol-6-ona
|
|
WO2011106639A1
(en)
*
|
2010-02-25 |
2011-09-01 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
PT2752422T
(pt)
|
2010-03-31 |
2017-11-07 |
Gilead Pharmasset Llc |
Síntese estereosseletiva de princípios ativos contendo fósforo
|
|
US8754190B2
(en)
|
2010-05-05 |
2014-06-17 |
Prolynx Llc |
Controlled release from macromolecular conjugates
|
|
CA3032185C
(en)
|
2010-07-13 |
2021-08-03 |
Council on Postsecondary Education, State of Rhode Island and Providence Plantations |
Environmentally sensitive composition comprising a ph triggered peptide and uses thereof
|
|
CA2808313C
(en)
|
2010-08-13 |
2021-04-13 |
Rhode Island Board Of Governors For Higher Education |
Liposomes comprising ph low insertion peptide (phlip) polypeptides
|
|
CA2816681A1
(en)
|
2010-11-03 |
2012-05-10 |
Immunogen, Inc. |
Cytotoxic agents comprising new ansamitocin derivatives
|
|
SG193997A1
(en)
|
2011-03-29 |
2013-11-29 |
Immunogen Inc |
Process for manufacturing conjugates of improved homogeneity
|
|
EA033468B1
(ru)
|
2011-03-29 |
2019-10-31 |
Immunogen Inc |
Способы получения конъюгата "антитело-майтансиноид"
|
|
US11135303B2
(en)
|
2011-10-14 |
2021-10-05 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
ES2671644T3
(es)
|
2012-10-11 |
2018-06-07 |
Daiichi Sankyo Company, Limited |
Conjugado de anticuerpo - fármaco
|
|
JP6272230B2
(ja)
|
2012-10-19 |
2018-01-31 |
第一三共株式会社 |
親水性構造を含むリンカーで結合させた抗体−薬物コンジュゲート
|
|
EP2911701A4
(en)
|
2012-10-23 |
2016-06-08 |
Univ Johns Hopkins |
Novel self-assembling drug amphiphiles and methods for synthesis and application
|
|
WO2014093343A2
(en)
|
2012-12-10 |
2014-06-19 |
Massachusetts Institute Of Technology |
Multistage nanoparticle drug delivery system for the treatment of solid tumors
|
|
WO2014134483A2
(en)
|
2013-02-28 |
2014-09-04 |
Immunogen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
TWI727919B
(zh)
|
2013-12-19 |
2021-05-21 |
美商西雅圖遺傳學公司 |
與標的-藥物結合物併用之亞甲基胺基甲酸酯連接物
|
|
WO2015108986A1
(en)
|
2014-01-16 |
2015-07-23 |
Clovis Oncology, Inc. |
Use of parp inhibitors to treat breast or ovarian cancer patients showing a loss of heterozygosity
|
|
JP2017114763A
(ja)
|
2014-03-26 |
2017-06-29 |
第一三共株式会社 |
抗ｃｄ９８抗体−薬物コンジュゲート
|
|
PT3129063T
(pt)
|
2014-04-10 |
2021-04-01 |
Daiichi Sankyo Europe Gmbh |
Conjugado anticorpo anti-her3-fármaco
|
|
JP6612738B2
(ja)
*
|
2014-04-10 |
2019-11-27 |
第一三共株式会社 |
抗ｈｅｒ２抗体−薬物コンジュゲート
|
|
CN106794185A
(zh)
|
2014-08-22 |
2017-05-31 |
克洛维斯肿瘤有限公司 |
Rucaparib的高剂量强度片剂
|
|
AU2015318018B2
(en)
|
2014-09-16 |
2017-05-11 |
Synermore Biologics (Suzhou) Co. Ltd. |
Anti-EGFR antibody and uses of same
|
|
AU2015349985A1
(en)
|
2014-11-19 |
2017-05-25 |
Immunogen, Inc. |
Process for preparing cell-binding agent-cytotoxic agent conjugates
|
|
MA43354A
(fr)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
Conjugués médicamenteux à pont disulfure encombré
|
|
LT3380486T
(lt)
|
2015-11-24 |
2020-05-11 |
Theravance Biopharma R&D Ip, Llc |
Jak inhibitoriaus junginio provaistai, skirti virškinimo trakto uždegiminės ligos gydymui
|
|
KR102498258B1
(ko)
|
2016-01-20 |
2023-02-10 |
삼성디스플레이 주식회사 |
표시 장치
|
|
US20170267727A1
(en)
|
2016-03-04 |
2017-09-21 |
Lehigh University |
Conjugates of pH Low Insertion Peptide and Monomethyl Auristatins in the Treatment of Solid Tumors
|
|
JP2019510085A
(ja)
|
2016-03-08 |
2019-04-11 |
ロス ガトス ファーマスーティカルズ， インク．Ｌｏｓ Ｇａｔｏｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
癌治療のためのナノ粒子ならびに方法および化合物
|
|
WO2017180834A1
(en)
*
|
2016-04-13 |
2017-10-19 |
Tarveda Therapeutics, Inc. |
Neurotensin receptor binding conjugates and formulations thereof
|
|
GB201608885D0
(en)
|
2016-05-20 |
2016-07-06 |
Univ Birmingham |
Treatment
|
|
WO2017210608A1
(en)
|
2016-06-02 |
2017-12-07 |
Yale University |
Compositions and methods for targeting and treating homologous recombination-deficient tumors
|
|
CA3032401A1
(en)
|
2016-07-29 |
2018-02-01 |
Memorial Sloan Kettering Cancer Center |
Radiolabeled ligands for targeted pet/spect imaging and methods of their use
|
|
JP6666613B2
(ja)
|
2016-08-16 |
2020-03-18 |
国立研究開発法人産業技術総合研究所 |
悪性腫瘍標的ペプチド
|
|
US11738096B2
(en)
|
2016-09-22 |
2023-08-29 |
Yale University |
Method of detecting diseased or damaged tissue with a pH-triggered polypeptide fluorophore composition
|
|
WO2018227132A1
(en)
|
2017-06-09 |
2018-12-13 |
Rhode Island Council On Postsecondary Education |
Linked and other ph-triggered compounds
|
|
CN117838881A
(zh)
|
2017-08-31 |
2024-04-09 |
第一三共株式会社 |
制备抗体-药物缀合物的新方法
|
|
AU2019205325A1
(en)
|
2018-01-05 |
2020-08-13 |
Cybrexa 1, Inc. |
Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
|
|
CA3087628A1
(en)
|
2018-01-12 |
2019-07-18 |
Prolynx Llc |
Synergistic cancer treatment
|
|
RS65580B1
(sr)
|
2018-05-18 |
2024-06-28 |
Daiichi Sankyo Co Ltd |
Anti-muc1-eksatekan antitelo-lek konjugat
|
|
TW202015740A
(zh)
|
2018-06-07 |
2020-05-01 |
美商西雅圖遺傳學公司 |
喜樹鹼結合物
|
|
CN109232719B
(zh)
|
2018-09-21 |
2021-06-29 |
中国科学院理化技术研究所 |
一种pH响应的抗菌肽及其制备方法和应用
|
|
US12029793B2
(en)
|
2019-01-28 |
2024-07-09 |
Yale University |
pH low insertion peptide targeted delivery of potent cytotoxic compounds
|
|
PL3946464T3
(pl)
|
2019-03-29 |
2022-12-19 |
Medimmune Limited |
Związki i ich koniugaty
|
|
EP3996749A1
(en)
|
2019-07-10 |
2022-05-18 |
Cybrexa 3, Inc. |
Peptide conjugates of microtubule-targeting agents as therapeutics
|